Home

Soligenix, Inc. - Common Stock (SNGX)

2.3300
+0.0200 (0.87%)

Soligenix Inc. is a biopharmaceutical company focused on developing innovative therapies for significant unmet medical needs

The company specializes in the research and clinical development of proprietary products aimed at treating rare diseases, as well as products intended for biodefense applications. With a strong emphasis on developing treatments for conditions such as oral mucositis and acute radiation syndrome, Soligenix takes a multi-faceted approach that includes leveraging its drug development platforms and engaging in collaborations with various stakeholders to advance its pipeline. The company’s dedication to improving patient outcomes drives its commitment to delivering safe and effective therapeutic options.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close2.310
Open2.310
Bid2.320
Ask2.400
Day's Range2.241 - 2.410
52 Week Range1.830 - 14.92
Volume26,426
Market Cap5.85M
PE Ratio (TTM)0.4905
EPS (TTM)4.8
Dividend & YieldN/A (N/A)
1 Month Average Volume620,874

News & Press Releases

Soligenix Targets Psoriasis With New Therapy
Soligenix Targets Psoriasis With New Therapy
Via News Direct · January 17, 2025
EXCLUSIVE: Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Yearbenzinga.com
Soligenix's IIS study on HyBryte for cutaneous T-cell lymphoma shows 70% success and strong safety profile, with Phase 3 enrollment ongoing.
Via Benzinga · January 14, 2025
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
Via News Direct · December 17, 2024
EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancerbenzinga.com
Soligenix opens enrollment for the Phase 3 FLASH2 study of HyBryte in early-stage CTCL, aiming to confirm extended treatment efficacy over 18 weeks.
Via Benzinga · December 16, 2024
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
Via News Direct · November 27, 2024
Soligenix Announces Participation at the Spartan Capital Investor Conference
Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement
Via TheNewswire.com · October 29, 2024
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City, NJ. Now in its second year, the event is a key gathering for microcap and small-cap investors, offering a platform for investment and collaboration.
Via ACCESSWIRE · November 27, 2024
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
PRINCETON, NJ / ACCESSWIRE / November 15, 2024 / Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will be presenting at the upcoming Q4 Investor Summit and will be available for 1-on-1 meetings throughout the day.
Via ACCESSWIRE · November 15, 2024
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vesselsbenzinga.com
Soligenix starts Phase 2 trial of SGX945 for Behçet's Disease, aiming to enroll 25 patients and report results by mid-2025. Trial includes efficacy assessments.
Via Benzinga · November 14, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · November 1, 2024
Soligenix Announces Participation at the Spartan Capital Investor Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 29, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · October 7, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 3, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 3, 2024
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 3, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 2, 2024
Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air interviews with Nova Minerals Limited (Nasdaq:NVA) and Soligenix Inc. (Nasdaq:SNGX) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · September 20, 2024
Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / August 16, 2024 / RedChip Companies will air interviews with Soligenix Inc. (Nasdaq:SNGX) and American Resources Corp. (Nasdaq:AREC) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, August 17, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · August 16, 2024
7 Top Stocks Under $10: July 2024 Editioninvestorplace.com
There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.
Via InvestorPlace · July 31, 2024
MarketBeat Week in Review – 7/8 - 7/12
Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the week
Via MarketBeat · July 13, 2024
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 10, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
Via InvestorPlace · July 10, 2024
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · July 10, 2024
Uncover Why This Pharma Stock Jumped 400% on Study Update
Shares of Soligenix (NASDAQSNGX), a late-stage biopharmaceutical company, surged almost 400% today after announcing positive data.
Via MarketBeat · July 10, 2024
S&P 500 Edges Higher; Indivior Shares Plummetbenzinga.com
Via Benzinga · July 9, 2024